Cargando…
Can Quantitative Muscle Strength and Functional Motor Ability Differentiate the Influence of Age and Corticosteroids in Ambulatory Boys with Duchenne Muscular Dystrophy?
Background: In the absence of a curative treatment for Duchenne Muscular Dystrophy (DMD), corticosteroid therapy (prednisone, deflazacort) has been adopted as the standard of care, as it slows the progression of muscle weakness and enables longer retention of functional mobility. The ongoing develop...
Autores principales: | Buckon, Cathleen, Sienko, Susan, Bagley, Anita, Sison-Williamson, Mitell, Fowler, Eileen, Staudt, Loretta, Heberer, Kent, McDonald, Craig M., Sussman, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956479/ https://www.ncbi.nlm.nih.gov/pubmed/27500011 http://dx.doi.org/10.1371/currents.md.1ced64dff945f8958221fddcd4ee60b0 |
Ejemplares similares
-
Prednisone and Deflazacort in Duchenne Muscular Dystrophy: Do They Play a Different Role in Child Behavior and Perceived Quality of Life?
por: Sienko, Susan, et al.
Publicado: (2016) -
Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016) -
Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy
por: Zamani, Gholamreza, et al.
Publicado: (2022) -
Efficacy of corticosteroid in decreasing scoliosis and extending time to loss of ambulation in a single clinic: an effectiveness trial
por: Sussman, Michael D., et al.
Publicado: (2020) -
Growth pattern trajectories in boys with Duchenne muscular dystrophy
por: Stimpson, Georgia, et al.
Publicado: (2022)